Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery
Clinical trial NCT03044730 · UNKNOWN
Trial details
- NCT number
- NCT03044730
- Sponsor
- Northwestern University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-25
- Primary completion
- 2019-04-24
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.